Serum Life Science

Company snapshot

Serum Life Science Europe GmbH (SLS Europe) – formerly Vakzine Projekt Management GmbH (VPM) – offers tailor-made consultancy and services supporting biopharmaceutical development in Europe and beyond. We offer exceptional knowledge in the development of biopharmaceutical candidates and a team that has vast experience in clinical and translational project management. This enables you to bring your

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Serum Life Science. Not investment advice.

• What is Serum Life Science?

  Serum Life Science is a pharma organization headquartered in EU. Primary therapeutic focus areas include Prophylaxis for the Measles Infection. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrial

• Is Serum Life Science publicly traded?

  Serum Life Science appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Serum Life Science develop or market?

  No drug profiles are currently linked to Serum Life Science. Pipeline programs may still list investigational assets.

• What are the latest developments for Serum Life Science?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Serum Life Science focus on?

  Serum Life Science focuses on Prophylaxis for the Measles Infection based on our analysis of their pipeline programs and drug development activities.